Parabilis Medicines, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Parabilis Medicines, Inc. (PBLS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 15.27 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- Parabilis Medicines, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 15.27M shares, a 68.22% decline year-over-year.
- Parabilis Medicines, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 48.04M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month |
|---|---|---|
| 2026-06-30 | 15.27M shares 10-Q · filed 2026-08-13 | 15.27M shares 10-Q · filed 2026-08-13 |
| 2025-06-30 | 48.04M shares 10-Q · filed 2026-08-13 | 48.04M shares 10-Q · filed 2026-08-13 |